Yu G - Search Results

1

Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.

Weng G, Huang J, He X, Xue T, Yang L, Zhang Y, Yu G, Sun Z, Lin D, Deng L, Liang X, Xiao J, Zhang H, Guo Z, Jin H, Liu Q, Du X. Weng G, et al. Among authors: yu g. Ann Hematol. 2023 Dec;102(12):3369-3381. doi: 10.1007/s00277-023-05452-7. Epub 2023 Sep 18. Ann Hematol. 2023. PMID: 37723307

2

[Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities].

Zhang Y, Chen YK, Liu QF, Fan ZP, Jiang QL, Zhao J, Wei Q, Li XF, Yu GP, Sun J, Chai YY. Zhang Y, et al. Zhonghua Yi Xue Za Zhi. 2011 May 31;91(20):1379-83. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21756807 Chinese.

3

[The outcome and safety of mesenchymal stem cells from bone marrow of a third party donor in treatment of secondary poor graft function following allogeneic hematopoietic stem cell transplantation].

Liu XD, Fan ZP, Peng YW, Huang F, Jiang QL, Zhang X, Yu GP, Zhao J, Sun J, Xiang P, Liu QF. Liu XD, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):98-102. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22730656 Chinese.

4

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.

Xuan L, Huang F, Fan Z, Zhou H, Zhang X, Yu G, Zhang Y, Liu C, Sun J, Liu Q. Xuan L, et al. Among authors: yu g. J Hematol Oncol. 2012 Aug 2;5:46. doi: 10.1186/1756-8722-5-46. J Hematol Oncol. 2012. PMID: 22856463 Free PMC article. Clinical Trial.

5

Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.

Liu QF, Fan ZP, Wu MQ, Sun J, Wu XL, Xu D, Jiang QL, Zhang Y, Huang F, Wei YQ, Zhao J, Yu GP, Meng FY. Liu QF, et al. Ann Hematol. 2013 May;92(5):679-87. doi: 10.1007/s00277-012-1662-4. Epub 2012 Dec 30. Ann Hematol. 2013. PMID: 23274355

6

[A comparison of toxicity and efficacy between busulfan plus fludarabine and busulfan plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia].

Liu H, Fan ZP, Jiang QL, Huang F, Zhou HS, Zhang X, Yu GP, Wu MQ, Sun J, Liu QF. Liu H, et al. Zhonghua Nei Ke Za Zhi. 2012 Nov;51(11):880-4. Zhonghua Nei Ke Za Zhi. 2012. PMID: 23291027 Chinese.

7

Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.

Liu X, Wu M, Peng Y, Chen X, Sun J, Huang F, Fan Z, Zhou H, Wu X, Yu G, Zhang X, Li Y, Xiao Y, Song C, Xiang AP, Liu Q. Liu X, et al. Among authors: yu g. Cell Transplant. 2014;23(9):1087-98. doi: 10.3727/096368912X661319. Cell Transplant. 2014. PMID: 23294601 Free article. Clinical Trial.

8

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.

Liu H, Zhai X, Song Z, Sun J, Xiao Y, Nie D, Zhang Y, Huang F, Zhou H, Fan Z, Tu S, Li Y, Guo X, Yu G, Liu Q. Liu H, et al. Among authors: yu g. J Hematol Oncol. 2013 Feb 8;6:15. doi: 10.1186/1756-8722-6-15. J Hematol Oncol. 2013. PMID: 23394705 Free PMC article. Clinical Trial.

9

Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation.

Xuan L, Jiang X, Sun J, Zhang Y, Huang F, Fan Z, Guo X, Dai M, Liu C, Yu G, Zhang X, Wu M, Huang X, Liu Q. Xuan L, et al. Among authors: yu g. Transplantation. 2013 Sep;96(6):560-6. doi: 10.1097/TP.0b013e31829d38af. Transplantation. 2013. PMID: 23842192

10

The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.

Jiang X, Wang Z, Ding B, Yin C, Zhong Q, Carter BZ, Yu G, Jiang L, Ye J, Dai M, Zhang Y, Liang S, Zhao Q, Liu Q, Meng F. Jiang X, et al. Among authors: yu g. Oncotarget. 2015 Oct 20;6(32):33612-22. doi: 10.18632/oncotarget.5600. Oncotarget. 2015. PMID: 26384351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,531 results

Search Page